These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24854887)

  • 1. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review.
    Leu-Semenescu S; Nittur N; Golmard JL; Arnulf I
    Sleep Med; 2014 Jun; 15(6):681-7. PubMed ID: 24854887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness.
    Inocente C; Arnulf I; Bastuji H; Thibault-Stoll A; Raoux A; Reimão R; Lin JS; Franco P
    Clin Neuropharmacol; 2012; 35(2):55-60. PubMed ID: 22356925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
    Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC;
    Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.
    Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I
    Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review.
    Leu-Semenescu S; Louis P; Arnulf I
    Sleep Med; 2016 Jan; 17():38-44. PubMed ID: 26847972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study.
    Dauvilliers Y; Arnulf I; Szakacs Z; Leu-Semenescu S; Lecomte I; Scart-Gres C; Lecomte JM; Schwartz JC;
    Sleep; 2019 Oct; 42(11):. PubMed ID: 31529094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized Trial.
    Pépin JL; Georgiev O; Tiholov R; Attali V; Verbraecken J; Buyse B; Partinen M; Fietze I; Belev G; Dokic D; Tamisier R; Lévy P; Lecomte I; Lecomte JM; Schwartz JC; Dauvilliers Y;
    Chest; 2021 Apr; 159(4):1598-1609. PubMed ID: 33121980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitolisant for treating patients with narcolepsy.
    Li S; Yang J
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):79-84. PubMed ID: 31937172
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.
    Uguen M; Perrin D; Belliard S; Ligneau X; Beardsley PM; Lecomte JM; Schwartz JC
    Br J Pharmacol; 2013 Jun; 169(3):632-44. PubMed ID: 23472741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
    Dauvilliers Y; Verbraecken J; Partinen M; Hedner J; Saaresranta T; Georgiev O; Tiholov R; Lecomte I; Tamisier R; Lévy P; Scart-Gres C; Lecomte JM; Schwartz JC; Pépin JL;
    Am J Respir Crit Care Med; 2020 May; 201(9):1135-1145. PubMed ID: 31917607
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials.
    Meskill GJ; Davis CW; Zarycranski D; Doliba M; Schwartz JC; Dayno JM
    CNS Drugs; 2022 Jan; 36(1):61-69. PubMed ID: 34935103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials.
    Wang J; Li X; Yang S; Wang T; Xu Z; Xu J; Gao H; Chen G
    Pharmacol Res; 2021 May; 167():105522. PubMed ID: 33667687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.
    Lavault S; Dauvilliers Y; Drouot X; Leu-Semenescu S; Golmard JL; Lecendreux M; Franco P; Arnulf I
    Sleep Med; 2011 Jun; 12(6):550-6. PubMed ID: 21576035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on treatment for idiopathic hypersomnia.
    Evangelista E; Lopez R; Dauvilliers Y
    Expert Opin Investig Drugs; 2018 Feb; 27(2):187-192. PubMed ID: 29250981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world treatment of pediatric narcolepsy with pitolisant: A retrospective, multicenter study.
    Triller A; Pizza F; Lecendreux M; Lieberich L; Rezaei R; Pech de Laclause A; Vandi S; Plazzi G; Kallweit U
    Sleep Med; 2023 Mar; 103():62-68. PubMed ID: 36758348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitolisant: First Global Approval.
    Syed YY
    Drugs; 2016 Sep; 76(13):1313-1318. PubMed ID: 27438291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine for Idiopathic Hypersomnia.
    Arnulf I; Leu-Semenescu S; Dodet P
    Sleep Med Clin; 2019 Sep; 14(3):333-350. PubMed ID: 31375202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.
    Khan Z; Trotti LM
    Chest; 2015 Jul; 148(1):262-273. PubMed ID: 26149554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.
    Szakacs Z; Dauvilliers Y; Mikhaylov V; Poverennova I; Krylov S; Jankovic S; Sonka K; Lehert P; Lecomte I; Lecomte JM; Schwartz JC;
    Lancet Neurol; 2017 Mar; 16(3):200-207. PubMed ID: 28129985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study.
    Mayer G; Benes H; Young P; Bitterlich M; Rodenbeck A
    J Sleep Res; 2015 Feb; 24(1):74-81. PubMed ID: 25196321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.